| Gem City Home Care, Llc | |
| 1700 Lyons Road, Suite A, Dayton, Ohio 45458 | |
| (937) 438-9100 | |
| Name | Gem City Home Care, Llc |
|---|---|
| Location | 1700 Lyons Road, Suite A, Dayton, Ohio |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 367785 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 40040, 43017, 43018, 43062, 43065, 43068, 43072, 43078, 43110, 43125, 43147, 43204, 43207, 43209, 43211, 43213, 43214, 43224, 43228, 43229, 43232, 43420, 43431, 45003, 45004, 45005, 45011, 45013, 45014, 45015, 45032, 45033, 45034, 45036, 45039, 45040, 45042, 45044, 45050, 45052, 45053, 45054, 45055, 45056, 45062, 45064, 45065, 45066, 45067, 45068, 45069, 45070, 45107, 45113, 45140, 45152, 45162, 45169, 45177, 45214, 45240, 45241, 45242, 45246, 45249, 45304, 45305, 45308, 45309, 45311, 45312, 45314, 45315, 45318, 45319, 45320, 45322, 45323, 45324, 45325, 45327, 45330, 45331, 45332, 45335, 45337, 45338, 45339, 45341, 45342, 45344, 45345, 45346, 45347, 45354, 45356, 45358, 45359, 45363, 45365, 45368, 45369, 45370, 45371, 45372, 45373, 45377, 45378, 45380, 45381, 45382, 45383, 45384, 45385, 45387, 45389, 45390, 45402, 45403, 45404, 45405, 45406, 45409, 45410, 45412, 45414, 45415, 45416, 45417, 45419, 45420, 45424, 45426, 45427, 45428, 45429, 45430, 45431, 45432, 45434, 45439, 45440, 45448, 45449, 45458, 45459, 45469, 45501, 45502, 45503, 45504, 45505, 45506 |
| NPI Number | 1790788776 |
| Organization Name | GEM CITY HOME CARE, LLC |
| Address | 8534 Yankee St Ste 2a, Dayton, OH 45458 |
| Phone Number | 937-438-9100 |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the company's ToleroMune(R) cat allergy treatment significantly reduced patients' symptoms in a recently completed, large-scale phase II clinical trial. The study also confirmed the treatment's highly favourable safety profile.
Race and geographic area play important roles in determining whether a patient with chronic kidney disease receives optimal care before developing kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
British scalp cooling expert, PAXMAN will showcase the latest model of the PAXMAN Scalp Cooling System at Arab Health 2019.
Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that a Phase 2 study of orally administered interferon-alpha for the prevention of influenza and winter colds has reached the midway point. The study in Perth, Australia achieved full target enrollment of 200 subjects and 98% of the subjects remain on study drug. Subjects in the study are receiving a lozenge containing interferon-alpha or a matching placebo once a day for 16 weeks.
Healthy cells in our body release nano-sized bubbles that transfer genetic material such as DNA and RNA to other cells. It's your DNA that stores the important information necessary for RNA to produce proteins and make sure they act accordingly.
› Verified 5 days ago
| Quality Rating: |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the company's ToleroMune(R) cat allergy treatment significantly reduced patients' symptoms in a recently completed, large-scale phase II clinical trial. The study also confirmed the treatment's highly favourable safety profile.
Race and geographic area play important roles in determining whether a patient with chronic kidney disease receives optimal care before developing kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
British scalp cooling expert, PAXMAN will showcase the latest model of the PAXMAN Scalp Cooling System at Arab Health 2019.
Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that a Phase 2 study of orally administered interferon-alpha for the prevention of influenza and winter colds has reached the midway point. The study in Perth, Australia achieved full target enrollment of 200 subjects and 98% of the subjects remain on study drug. Subjects in the study are receiving a lozenge containing interferon-alpha or a matching placebo once a day for 16 weeks.
Healthy cells in our body release nano-sized bubbles that transfer genetic material such as DNA and RNA to other cells. It's your DNA that stores the important information necessary for RNA to produce proteins and make sure they act accordingly.
› Verified 5 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 89.7 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 98 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.6 | 99.6 |
| How often the home health team checked patients for depression | 98.9 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 78.1 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 78.9 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 91.4 | 96.4 |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the company's ToleroMune(R) cat allergy treatment significantly reduced patients' symptoms in a recently completed, large-scale phase II clinical trial. The study also confirmed the treatment's highly favourable safety profile.
Race and geographic area play important roles in determining whether a patient with chronic kidney disease receives optimal care before developing kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
British scalp cooling expert, PAXMAN will showcase the latest model of the PAXMAN Scalp Cooling System at Arab Health 2019.
Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that a Phase 2 study of orally administered interferon-alpha for the prevention of influenza and winter colds has reached the midway point. The study in Perth, Australia achieved full target enrollment of 200 subjects and 98% of the subjects remain on study drug. Subjects in the study are receiving a lozenge containing interferon-alpha or a matching placebo once a day for 16 weeks.
Healthy cells in our body release nano-sized bubbles that transfer genetic material such as DNA and RNA to other cells. It's your DNA that stores the important information necessary for RNA to produce proteins and make sure they act accordingly.
› Verified 5 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 75.1 | 79.6 |
| How often patients got better at getting in and out of bed | 77.6 | 81.1 |
| How often patients got better at bathing | 78.6 | 82.3 |
| How often patients’ breathing improved | 75.2 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 90.3 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 68.1 | 75 |
| How often home health patients had to be admitted to the hospital | 15.5 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 15.2 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 96.6 | 94 |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the company's ToleroMune(R) cat allergy treatment significantly reduced patients' symptoms in a recently completed, large-scale phase II clinical trial. The study also confirmed the treatment's highly favourable safety profile.
Race and geographic area play important roles in determining whether a patient with chronic kidney disease receives optimal care before developing kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
British scalp cooling expert, PAXMAN will showcase the latest model of the PAXMAN Scalp Cooling System at Arab Health 2019.
Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that a Phase 2 study of orally administered interferon-alpha for the prevention of influenza and winter colds has reached the midway point. The study in Perth, Australia achieved full target enrollment of 200 subjects and 98% of the subjects remain on study drug. Subjects in the study are receiving a lozenge containing interferon-alpha or a matching placebo once a day for 16 weeks.
Healthy cells in our body release nano-sized bubbles that transfer genetic material such as DNA and RNA to other cells. It's your DNA that stores the important information necessary for RNA to produce proteins and make sure they act accordingly.
› Verified 5 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the company's ToleroMune(R) cat allergy treatment significantly reduced patients' symptoms in a recently completed, large-scale phase II clinical trial. The study also confirmed the treatment's highly favourable safety profile.
Race and geographic area play important roles in determining whether a patient with chronic kidney disease receives optimal care before developing kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
British scalp cooling expert, PAXMAN will showcase the latest model of the PAXMAN Scalp Cooling System at Arab Health 2019.
Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that a Phase 2 study of orally administered interferon-alpha for the prevention of influenza and winter colds has reached the midway point. The study in Perth, Australia achieved full target enrollment of 200 subjects and 98% of the subjects remain on study drug. Subjects in the study are receiving a lozenge containing interferon-alpha or a matching placebo once a day for 16 weeks.
Healthy cells in our body release nano-sized bubbles that transfer genetic material such as DNA and RNA to other cells. It's your DNA that stores the important information necessary for RNA to produce proteins and make sure they act accordingly.
› Verified 5 days ago
The patient survey data of Gem City Home Care, Llc is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 87 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 81 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 86 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 83 | 78 |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the company's ToleroMune(R) cat allergy treatment significantly reduced patients' symptoms in a recently completed, large-scale phase II clinical trial. The study also confirmed the treatment's highly favourable safety profile.
Race and geographic area play important roles in determining whether a patient with chronic kidney disease receives optimal care before developing kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
British scalp cooling expert, PAXMAN will showcase the latest model of the PAXMAN Scalp Cooling System at Arab Health 2019.
Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that a Phase 2 study of orally administered interferon-alpha for the prevention of influenza and winter colds has reached the midway point. The study in Perth, Australia achieved full target enrollment of 200 subjects and 98% of the subjects remain on study drug. Subjects in the study are receiving a lozenge containing interferon-alpha or a matching placebo once a day for 16 weeks.
Healthy cells in our body release nano-sized bubbles that transfer genetic material such as DNA and RNA to other cells. It's your DNA that stores the important information necessary for RNA to produce proteins and make sure they act accordingly.
› Verified 5 days ago
Public Health - Dayton & Montgomery County Location: 117 South Main Street, 2nd Floor, Dayton, Ohio 45422 Ratings: NA Phone: (937) 225-6078 | |
Academy Health Services Inc Location: 3320 Office Park Drive, Dayton, Ohio 45439 Ratings: Phone: (937) 293-6631 | |
Reid Home Health Location: 6450 Poe Avenue, Suite 118, Dayton, Ohio 45414 Ratings: Phone: (513) 576-8472 | |
Children's Home Care Of Dayton Location: 18 Children's Plaza, Dayton, Ohio 45404 Ratings: NA Phone: (937) 641-4663 | |
International Quality Healthcare Corporation Location: 6937 North Main Street, Dayton, Ohio 45415 Ratings: NA Phone: (937) 277-4888 | |
Gem City Home Care, Llc Location: 1700 Lyons Road, Suite A, Dayton, Ohio 45458 Ratings: Phone: (937) 438-9100 |